Ana Oaknin Selected Research

Ana Oaknin Research Topics

Disease

53	Neoplasms (Cancer) 01/2024 - 12/2011
50	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2010
28	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2024 - 12/2008
21	Carcinoma (Carcinomatosis) 01/2023 - 08/2010
20	Disease Progression 01/2024 - 02/2014
17	Endometrial Neoplasms (Endometrial Cancer) 04/2024 - 07/2015
10	Fatigue 10/2023 - 07/2010
9	Nausea 10/2023 - 07/2010
7	Ovarian Epithelial Carcinoma 01/2023 - 07/2014
6	Vomiting 04/2024 - 11/2017
6	Fallopian Tube Neoplasms 10/2023 - 07/2018
5	Anemia 12/2022 - 11/2017
5	Neutropenia 12/2022 - 07/2014
5	Asthenia 10/2021 - 11/2017
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 01/2020
3	Adenocarcinoma 01/2024 - 01/2020
3	Microsatellite Instability 01/2022 - 01/2021
3	Thrombocytopenia (Thrombopenia) 10/2021 - 12/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2017
3	Hypertension (High Blood Pressure) 07/2014 - 02/2014
2	Diarrhea 01/2024 - 08/2010
2	Arthralgia (Joint Pain) 12/2023 - 11/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2021
2	Vulvar Neoplasms (Vulvar Cancer) 04/2022 - 11/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Hemorrhage 10/2017 - 07/2014
2	Fistula 10/2017 - 02/2014
2	Ascites 10/2016 - 07/2014
2	Proteinuria 07/2014 - 05/2014
1	Pneumonia (Pneumonitis) 04/2024
1	Syncope (Fainting) 04/2024
1	Dyspnea (Shortness of Breath) 01/2024
1	Embolism (Embolus) 01/2024
1	Menorrhagia 01/2024
1	Exanthema (Rash) 12/2023
1	Adenosquamous Carcinoma 12/2023
1	Fever (Fevers) 12/2023

Drug/Important Bio-Agent (IBA)

49	PlatinumIBA 02/2024 - 12/2011
21	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2023 - 07/2010
19	rucaparibIBA 12/2022 - 01/2017
15	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 12/2013
14	Bevacizumab (Avastin)FDA Link 01/2024 - 12/2013
13	olaparibIBA 01/2023 - 07/2010
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2013
8	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 02/2014
7	dostarlimabIBA 11/2023 - 11/2020
6	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 12/2011
6	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2017
5	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 07/2018
5	PM 01183IBA 10/2023 - 01/2021
5	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 01/2010
5	Topotecan (Hycamtin)FDA LinkGeneric 01/2023 - 02/2014
4	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
4	pembrolizumabIBA 03/2024 - 10/2020
4	Monoclonal AntibodiesIBA 01/2024 - 11/2020
4	mirvetuximab soravtansineIBA 12/2023 - 07/2018
4	atezolizumabIBA 12/2023 - 01/2019
4	Alanine Transaminase (SGPT)IBA 11/2023 - 01/2020
3	NivolumabIBA 04/2024 - 11/2019
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2023 - 01/2020
3	Poly Adenosine Diphosphate RiboseIBA 01/2022 - 01/2021
3	CreatinineIBA 01/2021 - 10/2017
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 02/2014
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 10/2020
2	neratinibIBA 01/2024 - 10/2020
2	B7-H1 AntigenIBA 01/2024 - 01/2019
2	AntigensIBA 12/2023 - 10/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2023 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 01/2023
2	Formaldehyde (Formol)FDA Link 06/2023 - 01/2020
2	ParaffinIBA 06/2023 - 01/2020
2	cediranib (AZD2171)IBA 01/2023 - 01/2020
2	Circulating Tumor DNAIBA 01/2023 - 01/2019
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2019
2	Folate Receptor 1IBA 01/2023 - 01/2023
2	cemiplimabIBA 10/2022 - 10/2022
2	1-dodecylpyridoxal (PLD)IBA 11/2021 - 01/2010
2	ABTL0812IBA 01/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	lenvatinibIBA 01/2021 - 10/2020
2	trebananibIBA 10/2016 - 07/2014
1	Lipase (Acid Lipase)FDA Link 04/2024
1	IpilimumabIBA 04/2024
1	TransferasesIBA 04/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024
1	Amylases FDA Link 01/2024
1	Immunoglobulin G (IgG)IBA 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 11/2023

Therapy/Procedure

47	Therapeutics 04/2024 - 06/2010
43	Drug Therapy (Chemotherapy) 02/2024 - 08/2011
7	Immunotherapy 04/2024 - 01/2020
6	Radiotherapy 03/2024 - 02/2014
5	Hysterectomy 06/2023 - 03/2019
2	Aftercare (After-Treatment) 04/2022 - 10/2021
1	Brachytherapy 03/2024
1	Chemoradiotherapy 03/2024
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2024